GSK spinning out VC arm SR One

GSK spinning out VC arm SR One

Source: 
BioCentury
snippet: 

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) plans to spin out its corporate VC arm SR One, according to a source familiar with the matter.